Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Retained Earnings (2020 - 2025)

IceCure Medical (ICCM) has disclosed Retained Earnings for 6 consecutive years, with -$120.4 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 14.29% to -$120.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$120.4 million through Dec 2025, down 14.29% year-over-year, with the annual reading at -$120.4 million for FY2025, 14.29% down from the prior year.
  • Retained Earnings for Q4 2025 was -$120.4 million at IceCure Medical, down from -$105.4 million in the prior quarter.
  • The five-year high for Retained Earnings was -$58.4 million in Q4 2021, with the low at -$120.4 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$89.9 million, with a median of -$90.1 million recorded in 2023.
  • The sharpest move saw Retained Earnings fell 29.06% in 2022, then fell 14.29% in 2025.
  • Over 5 years, Retained Earnings stood at -$58.4 million in 2021, then dropped by 29.06% to -$75.4 million in 2022, then decreased by 19.43% to -$90.1 million in 2023, then decreased by 17.01% to -$105.4 million in 2024, then dropped by 14.29% to -$120.4 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$120.4 million, -$105.4 million, and -$90.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.